Earnings per Share (EPS) (Diluted): A company's net earnings or losses attributable to common shareholders per diluted share basis, which includes all convertible securities and debt, options and warrants.
Bio-Techne Corp (TECH) had Earnings per Share (EPS) (Diluted) of $1.05 for the most recently reported fiscal year, ending 2024-06-30.
| Income Statement Financials | |
$1.16B |
|
$168.10M |
|
$389.33M |
|
$769.73M |
|
$952.37M |
|
$206.69M |
|
$-21.00M |
|
$185.69M |
|
$185.69M |
|
$168.10M |
|
$168.10M |
|
$168.10M |
|
$168.10M |
|
$206.69M |
|
$318.40M |
|
157.71M |
|
160.77M |
|
$1.07 |
|
|
Earnings per Share (EPS) (Diluted) |
$1.05 |
| Balance Sheet Financials | |
$617.42M |
|
$251.15M |
|
$2.09B |
|
$2.70B |
|
$159.38M |
|
$319.00M |
|
$475.64M |
|
$635.02M |
|
$2.07B |
|
$589.11M |
|
$2.07B |
|
158.22M |
|
| Cash Flow Statement Financials | |
$298.98M |
|
$-203.03M |
|
$-122.40M |
|
$180.57M |
|
$151.79M |
|
$-28.78M |
|
$38.04M |
|
$-50.42M |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.87 |
|
-- |
|
-- |
|
0.13 |
|
0.15 |
|
66.41% |
|
17.83% |
|
17.83% |
|
27.47% |
|
16.02% |
|
14.50% |
|
$236.10M |
|
-- |
|
-- |
|
-- |
|
0.43 |
|
2.17 |
|
4.80 |
|
76.02 |
|
8.13% |
|
28.54% |
|
6.22% |
|
7.04% |
|
$13.08 |
|
$1.47 |
|
$1.86 |
|